The Emerging Link between HIV Therapy and Diabetes
- *Corresponding Author:
- Prakash S Bisen
School of Studies in Biotechnology
Jiwaji University, Gwalior, India
E-mail: [email protected]
Received date: Jun 14, 2016; Accepted date: Jul 14, 2016; Published date: Jul 21, 2016
Citation: Jadaun P, Kulkarni SS, Yadav D, Khopkar P, Bisen PS (2016) The Emerging Link between HIV Therapy and Diabetes. J Bone Marrow Res 4:168. doi:10.4172/2329-8820.1000168
Copyright: © 2016 Jadaun P et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The screening for the management of diabetes mellitus must be included into regular HIV clinical care and clinicians must consider the metabolic effects of combinatorial drug therapy for HIV infection and its outcome. Studies are desirable to conclude the pathophysiologic explanation for the high prevalence of diabetes among HIVinfected who are on ART, and cohort studies with significant sample size are required to support.